These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 11532693)

  • 1. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of recurrent IgA nephropathy following kidney transplantation.
    Kishi Y; Takai K; Akao J; Isoyama N; Matsumura M; Uchiyama K; Tsuchida M; Suga A; Naito K
    Transplant Proc; 2004 Sep; 36(7):2160-1. PubMed ID: 15518785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE; McNamee PT; Nelson WE; Maxwell AP
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
    Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT
    Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches.
    McDonald SP; Russ GR
    Transplantation; 2006 Sep; 82(6):759-62. PubMed ID: 17006322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of IgA nephropathy after renal transplantation.
    van der Boog PJ; de Fijter JW; Bruijn JA; van Es LA
    Ann Med Interne (Paris); 1999 Feb; 150(2):137-42. PubMed ID: 10392262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the clinical course and prognostic factors of posttransplantation immunoglobulin A nephropathy.
    Kiattisunthorn K; Premasathian N; Wongwiwatana A; Parichatikanond P; Cheunsuchon B; Vasuvattakul S
    Transplant Proc; 2008 Sep; 40(7):2349-54. PubMed ID: 18790233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
    Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular disease recurrence in second and subsequent kidney transplants.
    Kennedy C; Obilana A; O'Brien F; O'Kelly P; Dorman A; Denton M; Magee C; Conlon P
    Clin Nephrol; 2013 Jan; 79(1):31-6. PubMed ID: 23073068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of IgA nephropathy with crescents in kidney transplants.
    Mousson C; Charon-Barra C; Funes de la Vega M; Tanter Y; Justrabo E; Martin L; Rifle G
    Transplant Proc; 2007 Oct; 39(8):2595-6. PubMed ID: 17954186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
    Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
    Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation].
    Matsugami K; Naito T; Nitta K; Nihei H; Tanabe K; Toma H; Yamaguchi Y
    Nihon Jinzo Gakkai Shi; 1998 Jul; 40(5):322-8. PubMed ID: 9752688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.